Equities

GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,698.35
  • Today's Change-87.65 / -3.15%
  • Shares traded76.78k
  • 1 Year change+69.18%
  • Beta0.4621
Data delayed at least 15 minutes, as of Sep 19 2024 11:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue34,53732,51732,780
OPERATING EXPENSES
Cost of revenue total14,57113,94314,821
Selling, general and admin. expenses, total10,2699,9109,818
Depreciation/amortization695656680
Unusual expense(income)1,633106198
Other operating expenses, total610522471
Total operating expense27,78025,13925,990
Operating income6,7577,3786,790
Other, net49(3.72)34
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes8,1628,3647,790
Provision for income taxes2,2622,2883,983
Net income after taxes5,9006,0763,808
Minority interest------
Net income before extra. Items5,9006,0763,808
Total extraordinary items03013,140
Net income5,9006,10716,947
Inc.avail. to common excl. extra. Items5,9006,0763,808
Inc.avail. to common incl. extra. Items5,9006,10716,947
EPS RECONCILIATION
Basic/primary weighted average shares169169169
Basic/primary eps excl. extra items353622
Basic/primary eps incl. extra items3536100
Dilution adjustment------
Diluted weighted average shares169169169
Diluted eps excl. extra items353622
Diluted eps incl. extra items3536100
COMMON STOCK DIVIDENDS
DPS - common stock primary issue323230
Gross dividend - common stock5,4215,42115,247
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental161417
SUPPLEMENTAL INCOME
Depreciation, supplemental590559586
Total special items1,4279.40(119)
NORMALISED INCOME
Normalized income before taxes9,5898,3737,671
Effect of special items on income taxes3962.57(61)
Income tax excluding impact of special items2,6582,2903,922
Normalized income after tax6,9316,0833,750
Normalized income avail. to common6,9316,0833,750
Basic normalized EPS413622
Diluted normalized EPS413622
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.